$AKYA
Akoya Biosciences, Inc.

2023 Q4 Form 10-Q Financial Statement

#000155837023018324 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $26.49M $25.22M
YoY Change 24.83% 33.75%
Cost Of Revenue $9.867M $9.939M
YoY Change 7.57% 25.1%
Gross Profit $16.62M $15.28M
YoY Change 37.97% 40.06%
Gross Profit Margin 62.75% 60.58%
Selling, General & Admin $18.90M $19.02M
YoY Change -9.79% -4.54%
% of Gross Profit 113.71% 124.49%
Research & Development $4.670M $5.173M
YoY Change -27.41% -5.36%
% of Gross Profit 28.1% 33.86%
Depreciation & Amortization $2.106M $2.570M
YoY Change 10.78% 23.5%
% of Gross Profit 12.67% 16.82%
Operating Expenses $26.06M $26.83M
YoY Change -12.07% -2.66%
Operating Profit -$9.439M -$11.55M
YoY Change -46.34% -30.64%
Interest Expense -$1.380M -$2.239M
YoY Change 28.97% 101.89%
% of Operating Profit
Other Income/Expense, Net -$5.000K -$185.0K
YoY Change -97.92% 107.87%
Pretax Income -$10.82M -$12.90M
YoY Change -42.73% -27.73%
Income Tax -$22.00K $15.00K
% Of Pretax Income
Net Earnings -$10.80M -$12.92M
YoY Change -42.77% -27.73%
Net Earnings / Revenue -40.78% -51.22%
Basic Earnings Per Share -$0.26
Diluted Earnings Per Share -$0.22 -$0.51
COMMON SHARES
Basic Shares Outstanding 49.08M 48.94M
Diluted Shares Outstanding 40.64M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.13M $78.60M
YoY Change 2.35% -3.8%
Cash & Equivalents $83.13M $78.60M
Short-Term Investments $0.00
Other Short-Term Assets $3.794M $3.505M
YoY Change -43.91% -57.76%
Inventory $17.88M $18.75M
Prepaid Expenses
Receivables $16.99M $16.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $121.8M $116.9M
YoY Change 8.55% 4.66%
LONG-TERM ASSETS
Property, Plant & Equipment $10.73M $10.84M
YoY Change 5.46% 3.35%
Goodwill $18.26M $18.26M
YoY Change 0.0% 0.0%
Intangibles $17.41M $18.12M
YoY Change -13.15% -11.34%
Long-Term Investments
YoY Change
Other Assets $657.0K $654.0K
YoY Change -4.51% 92.35%
Total Long-Term Assets $58.58M $60.30M
YoY Change -8.23% -6.83%
TOTAL ASSETS
Total Short-Term Assets $121.8M $116.9M
Total Long-Term Assets $58.58M $60.30M
Total Assets $180.4M $177.2M
YoY Change 2.46% 0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.78M $11.89M
YoY Change 10.8% 45.5%
Accrued Expenses $13.43M $13.19M
YoY Change -18.68% -6.01%
Deferred Revenue $6.688M $6.850M
YoY Change 6.51% 16.58%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $767.0K $800.0K
YoY Change 23.71% 34.91%
Total Short-Term Liabilities $35.35M $35.52M
YoY Change -4.61% 12.12%
LONG-TERM LIABILITIES
Long-Term Debt $75.25M $63.82M
YoY Change 18.93% 21.06%
Other Long-Term Liabilities $15.20M $140.0K
YoY Change -7.09% -99.13%
Total Long-Term Liabilities $75.25M $63.96M
YoY Change 18.93% 21.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.35M $35.52M
Total Long-Term Liabilities $75.25M $63.96M
Total Liabilities $126.6M $115.3M
YoY Change 7.79% 13.71%
SHAREHOLDERS EQUITY
Retained Earnings -$230.1M -$219.3M
YoY Change 37.98% 48.28%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.77M $61.97M
YoY Change
Total Liabilities & Shareholders Equity $180.4M $177.2M
YoY Change 2.46% 0.45%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$10.80M -$12.92M
YoY Change -42.77% -27.73%
Depreciation, Depletion And Amortization $2.106M $2.570M
YoY Change 10.78% 23.5%
Cash From Operating Activities -$5.584M -$13.76M
YoY Change -44.2% 13.06%
INVESTING ACTIVITIES
Capital Expenditures $594.0K $830.0K
YoY Change -31.65% -121.91%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$594.0K -$830.0K
YoY Change -102.68% -111.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.08M -140.0K
YoY Change 7.86% -101.42%
NET CHANGE
Cash From Operating Activities -5.584M -13.76M
Cash From Investing Activities -594.0K -830.0K
Cash From Financing Activities 11.08M -140.0K
Net Change In Cash 4.899M -14.73M
YoY Change -78.12% -397.28%
FREE CASH FLOW
Cash From Operating Activities -$5.584M -$13.76M
Capital Expenditures $594.0K $830.0K
Free Cash Flow -$6.178M -$14.59M
YoY Change -43.2% 74.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#OperatingExpenses
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40639714
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37612331
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#OperatingExpenses
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39489261
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37538821
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48821941
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38288188
dei Entity Central Index Key
EntityCentralIndexKey
0001711933
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
496000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48821941
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38288188
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40344
dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
896-8401
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AKYA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49076173
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78595000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74229000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6989000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16096000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9729000
CY2023Q3 us-gaap Inventory Net
InventoryNet
18752000
CY2022Q4 us-gaap Inventory Net
InventoryNet
14486000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3505000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6764000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
116948000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
112197000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10843000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10174000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
330000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
303000
CY2023Q3 akya Demo Inventory Net
DemoInventoryNet
1305000
CY2022Q4 akya Demo Inventory Net
DemoInventoryNet
2084000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18123000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20048000
CY2023Q3 us-gaap Goodwill
Goodwill
18262000
CY2022Q4 us-gaap Goodwill
Goodwill
18262000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9003000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10785000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1776000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1490000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
654000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
688000
CY2023Q3 us-gaap Assets
Assets
177244000
CY2022Q4 us-gaap Assets
Assets
176031000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11890000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10628000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13194000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16519000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2790000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3009000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
799000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
620000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6850000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6279000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
35523000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37055000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2782000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2114000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63818000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63277000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
87000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
87000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6752000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8203000
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
914000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
675000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5255000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
6039000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
140000
CY2023Q3 us-gaap Liabilities
Liabilities
115271000
CY2022Q4 us-gaap Liabilities
Liabilities
117450000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49062360
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38288188
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281240000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
225333000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219269000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166748000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
61973000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58581000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177244000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176031000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
9939000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
7945000
us-gaap Cost Of Revenue
CostOfRevenue
30461000
us-gaap Cost Of Revenue
CostOfRevenue
22296000
CY2023Q3 us-gaap Gross Profit
GrossProfit
15276000
CY2022Q3 us-gaap Gross Profit
GrossProfit
10907000
us-gaap Gross Profit
GrossProfit
39685000
us-gaap Gross Profit
GrossProfit
31344000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19017000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19922000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63483000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58705000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5173000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5466000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17219000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16778000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
262000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
357000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1019000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-599000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2375000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1815000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6193000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4975000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
26827000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27560000
us-gaap Operating Expenses
OperatingExpenses
87914000
us-gaap Operating Expenses
OperatingExpenses
79859000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11551000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16653000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48229000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48515000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2239000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1109000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6468000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2707000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1074000
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
136000
us-gaap Interest And Other Income
InterestAndOtherIncome
2576000
us-gaap Interest And Other Income
InterestAndOtherIncome
212000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-225000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-338000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-607000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12901000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17851000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52459000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51617000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48975432
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37900821
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42686065
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37660814
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
26000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-66000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
26000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12916000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17846000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52515000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51832000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58581000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
94000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18802000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2375000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
42124000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
143000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47817000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2620000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71901000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
110000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2878000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
61973000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1545000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106552000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
164000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-92000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
90850000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
26000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2044000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
75088000
us-gaap Profit Loss
ProfitLoss
-52521000
us-gaap Profit Loss
ProfitLoss
-51766000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6784000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5248000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
541000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
381000
us-gaap Share Based Compensation
ShareBasedCompensation
7873000
us-gaap Share Based Compensation
ShareBasedCompensation
5310000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
99000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1019000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-599000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
5000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
160000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-82000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
1782000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
-898000
akya Change In Inventory Reserve Adjustment
ChangeInInventoryReserveAdjustment
2600000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6367000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-764000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2547000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
255000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7040000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3976000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1262000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1263000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3359000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
987000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1670000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1018000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1239000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1539000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45315000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43489000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3059000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6491000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
40774000
akya Maturities Of Payments To Acquire Marketable Securities
MaturitiesOfPaymentsToAcquireMarketableSecurities
7000000
akya Maturities Of Payments To Acquire Marketable Securities
MaturitiesOfPaymentsToAcquireMarketableSecurities
11000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3941000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36210000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47995000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
311000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
259000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
94000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
20000000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
496000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
458000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
138000
akya Refunds From Payments Of Deferred Offering Costs
RefundsFromPaymentsOfDeferredOfferingCosts
-207000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1709000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1207000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45767000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18456000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4393000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-61243000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74532000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113381000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78925000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52138000
us-gaap Interest Paid Net
InterestPaidNet
5678000
us-gaap Interest Paid Net
InterestPaidNet
2189000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56000
akya Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
914000
akya Unpaid Stock Offering Costs
UnpaidStockOfferingCosts
178000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
521000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
352000
akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78595000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219269000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45315000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1847000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2023Q3 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
78595000
CY2023Q3 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
78595000
CY2022Q4 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
81224000
CY2022Q4 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses
6000
CY2022Q4 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
81218000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19619000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16499000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8776000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6325000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10843000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10174000
akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2022 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2023Q3 akya Demo Inventory Gross
DemoInventoryGross
4472000
CY2022Q4 akya Demo Inventory Gross
DemoInventoryGross
4453000
CY2023Q3 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
3167000
CY2022Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
2369000
CY2023Q3 akya Demo Inventory Net
DemoInventoryNet
1305000
CY2022Q4 akya Demo Inventory Net
DemoInventoryNet
2084000
CY2023Q3 akya Depreciation Demo Inventory
DepreciationDemoInventory
320000
akya Depreciation Demo Inventory
DepreciationDemoInventory
972000
CY2022Q3 akya Depreciation Demo Inventory
DepreciationDemoInventory
314000
akya Depreciation Demo Inventory
DepreciationDemoInventory
959000
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
16096000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
30289000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12166000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18123000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29544000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9496000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20048000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
713000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2853000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2853000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2823000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1956000
CY2023Q3 akya Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
6925000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18123000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6963000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8288000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1803000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1709000
CY2023Q3 akya Accrued Inventory Purchases
AccruedInventoryPurchases
600000
CY2022Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
488000
CY2023Q3 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
1550000
CY2022Q4 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
3652000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2278000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2382000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13194000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16519000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
478000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
565000
CY2023Q3 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
546000
CY2022Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
92000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
63818000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
63277000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2022 akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49062360
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38288188
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8967421
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7834432
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48975432
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37900821
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42686065
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37660814
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7116558
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6981590
akya Entity Number Of Business Activities
EntityNumberOfBusinessActivities
1
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
akya Number Of Countries With Concentration Risk
NumberOfCountriesWithConcentrationRisk
0
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
41000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
18000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
105000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
38000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1071000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1023000
us-gaap Lease Cost
LeaseCost
3173000
us-gaap Lease Cost
LeaseCost
2858000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
802000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2777000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2839000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2636000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1104000
CY2023Q3 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
997000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11155000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1613000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9542000
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
216000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
798000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
444000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
239000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
239000
CY2023Q3 akya Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
60000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1996000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
283000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1713000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0932
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0719
us-gaap Operating Lease Payments
OperatingLeasePayments
2328000
us-gaap Operating Lease Payments
OperatingLeasePayments
2211000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
105000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
39000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
458000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
2056000
CY2023Q3 akya Accrued Liabilities Restructuring Charges
AccruedLiabilitiesRestructuringCharges
79000

Files In Submission

Name View Source Status
akya-20230930_cal.xml Edgar Link unprocessable
R41.htm Edgar Link pending
0001558370-23-018324-index-headers.html Edgar Link pending
0001558370-23-018324-index.html Edgar Link pending
0001558370-23-018324.txt Edgar Link pending
0001558370-23-018324-xbrl.zip Edgar Link pending
akya-20230930.xsd Edgar Link pending
akya-20230930x10q.htm Edgar Link pending
akya-20230930xex31d1.htm Edgar Link pending
akya-20230930xex31d2.htm Edgar Link pending
akya-20230930xex32d1.htm Edgar Link pending
akya-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
akya-20230930_def.xml Edgar Link unprocessable
akya-20230930_lab.xml Edgar Link unprocessable
akya-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
akya-20230930x10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending